Role of SHP2 in hematopoiesis and leukemogenesis

Ruchi Pandey, Mallika Saxena, Reuben Kapur

Research output: Contribution to journalReview article

13 Scopus citations


Purpose of review: SH2 domain-containing tyrosine phosphatase 2 (SHP2), encoded by PTPN11 plays an important role in regulating signaling from cell surface receptor tyrosine kinases during normal development as well as oncogenesis. Herein we review recently discovered roles of SHP2 in normal and aberrant hematopoiesis along with novel strategies to target it. Recent findings: Cell autonomous role of SHP2 in normal hematopoiesis and leukemogenesis has long been recognized. The review will discuss the newly discovered role of SHP2 in lineage specific differentiation. Recently, a noncell autonomous role of oncogenic SHP2 has been reported in which activated SHP2 was shown to alter the bone marrow microenvironment resulting in transformation of donor derived normal hematopoietic cells and development of myeloid malignancy. From being considered as an 'undruggable' target, recent development of allosteric inhibitor has made it possible to specifically target SHP2 in receptor tyrosine kinase driven malignancies. Summary: SHP2 has emerged as an attractive target for therapeutic targeting in hematological malignancies for its cell autonomous and microenvironmental effects. However a better understanding of the role of SHP2 in different hematopoietic lineages and its crosstalk with signaling pathways activated by other genetic lesions is required before the promise is realized in the clinic.

Original languageEnglish (US)
Pages (from-to)307-313
Number of pages7
JournalCurrent opinion in hematology
Issue number4
StatePublished - Jul 1 2017


  • Ptpn11
  • SHP2
  • hematopoiesis
  • myeloid malignancy

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Role of SHP2 in hematopoiesis and leukemogenesis'. Together they form a unique fingerprint.

  • Cite this